Mounjaro Price at Dischem South Africa – Get Tested South Africa

Key Takeaways

  • Mounjaro at Dischem costs roughly R3,600 – R8,200+ per pen, depending on the dosage

  • Stock availability can be inconsistent, which may require you to contact multiple branches.

  • You need a valid prescription,obtainable from any SA qualified doctor

  • Additional costs beyond the medication (typically R100–R3,000) include consultations and follow-up care, which are important for ensuring safe, effective treatment and better long-term results

  • Treatment interruptions can occur due to supply shortages impacting results

  • Telehealth alternatives, including assessment, prescription, and home delivery

View our treatment options

Price of Mounjaro at Dischem

The latest price of the Mounjaro SEP (updated 05/2026) is R 3 605,58 - R 8 167,60.

However, the medication price is only one part. When comparing costs, it’s essential to consider more than just the pen price to get the full picture.

Have a script for Mounjaro?

Get it delivered to your door

The Other "Hidden Costs"

Many people don’t realise that getting Mounjaro involves more than just the medication it self. Especially if you want to get the best outcomes and avoid the side-effects. Extra costs outside of medication can include:

  • Monitoring Progress - Consultations, lab testing (R1000 - R3000)

  • Extra Equipment - Needles, alcohol swabs (R200 - R300)

  • Delivery/Logistics - Time to collect medication or get it delivered (R100 - R300)

Without proper guidance, you may not only pay more but get worse side effects and slower weight loss.

A real-world study found that patients who actively engaged with a digital weight management programme while using GLP-1-based weight-loss medication achieved 26.5% greater weight loss, demonstrating that expert-guided support can meaningfully enhance results.[1]

Is Mounjaro currently available at Dischem pharmacy?

While Dis-Chem (and other major pharmacies) stocks Mounjaro, availability can still vary between branches. Supply was previously inconsistent due to high global demand, although this is gradually improving. However, your specific dose may not always be available at every location, so it’s best to call ahead to confirm stock or consider order through a telehealth provider online.

Online vs Pharmacy: Getting Mounjaro Prescribed Through Telehealth

Feature

Traditional Pharmacy

Telehealth (Get Tested)

Medical Assessment

Separate doctor visit

Included in program

Medication Available

Sometimes

Always

Convienence

In store visits

Fully online

Delivery

In-person collection

To your door

Costs

Extra consultations/travel costs

Transparent pricing

Ongoing Support

Variable

Ongoing support and blood test monitoring

What Kind of Results Can You Actually Expect with Mounjaro?

Tirzepatide has been shown to be an effective option for weight management when used alongside lifestyle changes such as a reduced-calorie diet and increased physical activity. In clinical trials, patients lost an average of approximately 15–22% of their body weight at higher maintenance doses, although individual results can vary depending on dose, adherence, baseline metabolic health, and other personal medical factors.[2] In addition to supporting weight loss, tirzepatide has been associated with improvements in blood sugar control and other cardiometabolic health markers, including waist circumference and lipid profiles. [3]

Ozempic vs. Mounjaro: Which Injectable Delivers the Maximum Weight Loss?

Ozempic® (semaglutide) and Mounjaro® (tirzepatide) are both injectable medications used for blood sugar control and weight loss, but they work slightly differently. Ozempic® targets the GLP-1 receptor, while Mounjaro® acts on both GLP-1 and GIP receptors, which may lead to greater appetite suppression and weight loss for some patients.

Clinical trials show that patients using Ozempic® (semaglutide) lose on average around 15% of their body weight over 12–18 months [2]. In comparison, Mounjaro® (tirzepatide) has demonstrated greater average weight loss of approximately 20–22% [3], with some studies reporting even greater reductions in certain populations. However, greater efficacy comes with trade-offs. Mounjaro® is generally more expensive than semaglutide-based treatments and, like all GLP-1–based medications, may cause gastrointestinal side effects such as nausea, vomiting, diarrhoea and constipation. Some evidence suggests these side effects may occur more frequently at higher tirzepatide doses.

Orignal Mounjaro® vs Non-branded tirzepatide: what’s the difference?

Compounded tirzepatide is often a more affordable alternative to branded tirzepatide products such as Mounjaro®, as it is prepared by licensed compounding pharmacies and typically offered at a lower cost. It contains the same active ingredient (tirzepatide), although different inactive ingredients may be used in the formulation.

To help ensure quality and safety, compounded tirzepatide should only be sourced from reputable, licensed compounding pharmacies that follow appropriate manufacturing and quality-control standards. While compounded formulations may offer a lower-cost option, they have not undergone the same large-scale clinical trials and manufacturing standardisation processes as branded products.

For patients seeking a more cost-effective treatment option under medical supervision, compounded tirzepatide may be a practical alternative, with pricing typically starting from approximately R4 500.00 depending on the provider and formulation.

View our compounded programs

shield-plus

Get Started

Request treatment & complete a medical survey

drop

Get Tested

Visit a Nearby Lab & Consult with a Doctor

star

Get Results

Start losing weight & receive ongoing care

References

  1. Johnson H, Huang D, Liu V, Ammouri MA, Jacobs C, El-Osta A. Impact of digital engagement on weight loss outcomes in obesity management among individuals using GLP-1 and dual GLP-1/GIP receptor agonist therapy: retrospective cohort service evaluation study. Journal of Medical Internet Research. 2025;27:e69466. 🔗 https://www.jmir.org/2025/1/e69466/

  2. Sinha R, Papamargaritis D, Sargeant JA, Davies MJ. Efficacy and safety of tirzepatide in type 2 diabetes and obesity management. J Obes Metab Syndr. 2023.🔗 https://pubmed.ncbi.nlm.nih.gov/36750526/

  3. Rosenstock J, et al. Greater weight loss with tirzepatide and associated cardiometabolic improvements: pooled SURPASS analysis. Diabetes Care. 2023.🔗 https://pubmed.ncbi.nlm.nih.gov/37824793/

  4. Aamir AB, Latif R, Alqoofi JF, Almarzoq FA, Fallatah JO, Hassan GA, Al Abu Saab FAA. Comparative efficacy of tirzepatide vs. semaglutide in reducing body weight in humans: a systematic review and meta-analysis of clinical trials and real-world data. Cureus. 2025.

#71c2f1

#71c2f1